Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dong-Lak Choi, Professor
Daegu Catholic University Medical Center
Principal Investigator - Giwon Song, Professor
Asan Medical Center
Principal Investigator - Jaewon Joh, Professor
Samsung Medical Center
Principal Investigator - Myung Soo Kim, professor
Severance Hospital
Principal Investigator - Namjoon Lee, Professor
Seoul National University
Principal Investigator - SUNG-GYU LEE, Professor
Asan Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Asan Medical Center
Seoul, Seoul, South Korea
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 30 Jun 2014
- Completion
- 31 Dec 2014
- Last update posted
- 1 Nov 2013
- Registered enrollment
- 172
- Registry id
- NCT01974375
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.